# Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy

> **NCT02355665** · PHASE3 · COMPLETED · sponsor: **McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.** · enrollment: 1198 (actual)

## Conditions studied

- Tobacco Dependence

## Interventions

- **DRUG:** Nicotine Spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02355665
- **Lead sponsor:** McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-31
- **Primary completion:** 2015-09-30
- **Final completion:** 2016-02-10
- **Target enrollment:** 1198 (ACTUAL)
- **Last updated:** 2019-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02355665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02355665, "Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02355665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*